Literature DB >> 16881835

Effect of continuous intravenous administration of a 50% dextrose solution on phosphorus homeostasis in dairy cows.

Walter Grünberg1, Dawn E Morin, James K Drackley, Anne M Barger, Peter D Constable.   

Abstract

OBJECTIVE: To determine the effect of continuous IV administration of 50% dextrose solution on phosphorus homeostasis in lactating dairy cows.
DESIGN: Clinical trial. ANIMALS: 4 multiparous Jersey cows. PROCEDURES: Cows were administered 50% dextrose solution IV (0.3 g/kg/h [0.14 g/lb/h]) for 5 days. Plasma concentrations of glucose, immune-reactive insulin (IRI), and phosphorus were determined before, during, and for 72 hours after dextrose infusion. Phosphorus intake and losses of phosphorus in urine, feces, and milk were determined. Each cow received a sham treatment that included instrumentation and sampling but not administration of dextrose.
RESULTS: Plasma glucose, IRI, and phosphorus concentrations were stable during sham treatment. Plasma phosphorus concentration decreased rapidly after onset of dextrose infusion, reaching a nadir in 24 hours and remaining less than baseline value for 36 hours. Plasma phosphorus concentration increased after dextrose infusion was stopped, peaking in 6 hours. Urinary phosphorus excretion did not change during dextrose infusion, but phosphorus intake decreased because of reduced feed intake, followed by decreased fecal phosphorus loss and milk yield. Rapid changes in plasma phosphorus concentration at the start and end of dextrose infusion were temporally associated with changes in plasma glucose and IRI concentrations and most likely caused by compartmental shifts of phosphorus. CONCLUSIONS AND CLINICAL RELEVANCE: Hypophosphatemia developed in response to hyperglycemia or hyperinsulinemia in dairy cows administered dextrose via continuous IV infusion. Veterinarians should monitor plasma phosphorus concentration when administering dextrose in this manner, particularly in cows with decreased appetite or preexisting hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16881835     DOI: 10.2460/javma.229.3.413

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Red blood cell phosphate concentration and osmotic resistance during dietary phosphate depletion in dairy cows.

Authors:  W Grünberg; J A Mol; E Teske
Journal:  J Vet Intern Med       Date:  2014-11-19       Impact factor: 3.333

2.  Effect of Intravenous Small-Volume Hypertonic Sodium Bicarbonate, Sodium Chloride, and Glucose Solutions in Decreasing Plasma Potassium Concentration in Hyperkalemic Neonatal Calves with Diarrhea.

Authors:  F M Trefz; P D Constable; I Lorenz
Journal:  J Vet Intern Med       Date:  2017-04-13       Impact factor: 3.333

3.  Refeeding syndrome in small ruminants receiving parenteral nutrition.

Authors:  Daniela Luethy; Darko Stefanovski; Raymond W Sweeney
Journal:  J Vet Intern Med       Date:  2020-06-26       Impact factor: 3.333

4.  Comparative study on 3 oral potassium formulations for treatment of hypokalemia in dairy cows.

Authors:  Thomas Wittek; Anja Elvira Müller; Franz Wolf; Stephanie Schneider
Journal:  J Vet Intern Med       Date:  2019-05-17       Impact factor: 3.333

Review 5.  Intravenous and Oral Fluid Therapy in Neonatal Calves With Diarrhea or Sepsis and in Adult Cattle.

Authors:  Peter D Constable; Florian M Trefz; Ismail Sen; Joachim Berchtold; Mohammad Nouri; Geoffrey Smith; Walter Grünberg
Journal:  Front Vet Sci       Date:  2021-01-27

6.  Structure-function aspects of PstS in multi-drug-resistant Pseudomonas aeruginosa.

Authors:  Olga Zaborina; Christopher Holbrook; Yimei Chen; Jason Long; Alexander Zaborin; Irina Morozova; Hoylan Fernandez; Yingmin Wang; Jerrold R Turner; John C Alverdy
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

Review 7.  Treatment of calf diarrhea: intravenous fluid therapy.

Authors:  Joachim Berchtold
Journal:  Vet Clin North Am Food Anim Pract       Date:  2009-03       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.